Dr. Meghan Chenoweth has been a Project Scientist at CAMH since late 2019. She completed a BSc in Bio-Medical Science at the University of Guelph, an MSc in Medical Sciences at McMaster University, followed by a PhD and postdoctoral studies in Pharmacology at the University of Toronto. At CAMH, Dr. Chenoweth’s research is in the area of Pharmacogenetics, with a focus on understanding biological mechanisms of nicotine dependence and optimizing smoking cessation treatment approaches.
Areas of Research
Tobacco use is strongly influenced by genetic (i.e. biological) factors and differs by gender and by race. Dr. Chenoweth is an early career researcher studying intersections between genetics, sex and gender, and tobacco use behaviours. She is especially passionate about advancing our understanding of these relationships in diverse and vulnerable populations including African Americans, youth, and individuals living with psychiatric disorders. Her work spans the entire tobacco use continuum, from uptake through to cessation, and she leverages genome-wide approaches, sex-based analysis, and biomarkers of tobacco use to answer her research questions. Dr. Chenoweth’s work is funded by the Canadian Institute of Health Research.
View Dr. Chenoweth’s publications on PubMed.